Zoetis (ZTS) Cost of Revenue (2012 - 2026)

Zoetis (ZTS) has 15 years of Cost of Revenue data on file, last reported at $641.0 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $641.0 million, up 3.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 billion (changed 0.33% YoY), and the FY2025 annual result was $2.7 billion, down 1.95% from the prior year.
• Cost of Revenue eased to $641.0 million in Q1 2026 per ZTS's latest filing, from $712.0 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $728.0 million in Q4 2023 and troughed at $569.0 million in Q1 2022.
• A 5-year average of $649.2 million and a median of $643.0 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue grew 11.49% in 2023, then declined 3.89% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $653.0 million in 2022, then rose by 11.49% to $728.0 million in 2023, then fell by 2.88% to $707.0 million in 2024, then grew by 0.71% to $712.0 million in 2025, then declined by 9.97% to $641.0 million in 2026.
• Business Quant data shows ZTS's Cost of Revenue at $641.0 million in Q1 2026, $712.0 million in Q4 2025, and $683.0 million in Q3 2025.